Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Pressure BioSciences, Inc.    PBIO   US74112E1091

SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

Pressure Biosciences : Pressure BioSciences, Inc. to Present at the Rodman & Renshaw 8th Annual Healthcare Conference

11/02/2006 | 10:15am US/Eastern

Pressure BioSciences, Inc. (NASDAQ: PBIO) today announced that it will present at the Rodman & Renshaw 8th Annual Healthcare Conference to be held at the New York Palace Hotel, New York, NY on November 6-8, 2006. Mr. Richard T. Schumacher, PBI President and CEO, will give a corporate overview at 9:55 am (EST) on Wednesday, November 8th. Investors will be able to hear the presentation starting on November 8th and for approximately 90 days thereafter at http://www.wsw.com/webcast/rrshq10/pbio/.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (PBI) is a publicly traded, early-stage company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 5 foreign patents covering multiple applications of PCT in the life sciences field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of enzymes, immunodiagnostics, and protein purification.

Forward Looking Statements

Statements contained in this press release regarding the Company's intentions, hopes, beliefs, expectations, or predictions of the future are "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based upon the Company's current expectations, forecasts, and assumptions that are subject to risks, uncertainties, and other factors that could cause actual outcomes and results to differ materially from those indicated by these forward-looking statements. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading "Risk Factors" in the Company's Quarterly Report on Form 10-QSB for the quarter ended June 30, 2006, in the Company's Annual Report on Form 10-KSB, as amended, for the year ended December 31, 2005, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

Visit us at our website http://www.pressurebiosciences.com


© Business Wire 2006
Latest news on PRESSURE BIOSCIENCES, INC.
09/29 PRESSURE BIOSCIENCES INC : Pressure Biosciences, Inc. (PBIO) Benefits From Surge..
09/24 PRESSURE BIOSCIENCES : Announces Completion of the First Phase of Its Commercial..
09/15 PRESSURE BIOSCIENCES INC : Steady Growth and Cutting-Edge Technologies Are Trade..
09/15 PRESSURE BIOSCIENCES : Steady Growth and Cutting-Edge Technologies Are Trademark..
09/08 PRESSURE BIOSCIENCES INC : SeeThruEquity Fall Microcap Investor Conference To Be..
08/27 PRESSURE BIOSCIENCES : "PBI") (OTCQB: PBIO), Exclusive Interview for Interlinked..
08/13 PRESSURE BIOSCIENCES : "PBI") (OTCQB: PBIO) to Discuss Second Quarter 2014 Finan..
07/15 PRESSURE BIOSCIENCES : OTCQB: PBIO) to Present at the FSXinterlinked Investment ..
07/02 PRESSURE BIOSCIENCES : Engages IssuWorks in Strategic Advisory Role
07/01 PRESSURE BIOSCIENCES : "PBI") (OTCQB: PBIO), Exclusive Interview for Interlinked..
Advertisement
Dynamic quotes  
ON
| OFF